S'abonner

Characteristics of infections and their risk factors in children with biliary atresia - 31/03/23

Doi : 10.1016/j.clinre.2023.102109 
Henry Shiau a, , Jeremy M. Schraw b, c, Krupa Mysore a, Laurel Cavallo a, Sanjiv Harpavat a, Philip J. Lupo b, c, Flor M. Munoz d, Benjamin L. Shneider a
a Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, U.S.A. 
b Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas, U.S.A. 
c Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, Texas, U.S.A. 
d Department of Pediatrics, Section of Infectious Diseases, Molecular Virology and Microbiology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, U.S.A. 

Corresponding author at: Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, The University of Alabama at Birmingham, Children's of Alabama, 5604 McWane Building, Dearth Tower Birmingham, AL 35233-1711.Division of Gastroenterology, Hepatology, and Nutrition, Department of PediatricsThe University of Alabama at Birmingham, Children's of Alabama5604 McWane Building, Dearth Tower BirminghamAL35233-1711

Highlights

The infectious course of children with biliary atresia (BA) post-kasai is described.
Cluster analysis recognizes three distinct infectious cohorts of children with BA.
Age at kasai and platelets 1-month post-kasai are potential infectious risk factors.

Le texte complet de cet article est disponible en PDF.

Abstract

Background

Children with biliary atresia (BA) may experience various infections (e.g., cholangitis, bacteremia, and viral respiratory infections (VRI)) throughout their disease course. This study aimed to identify and describe these infections and their risk factors for development in children with BA.

Methods

This retrospective observational study identified infections in children with BA using predefined criteria, including VRI, bacteremia with and without central line (CL), bacterial peritonitis, positive stool pathogens, urinary tract infections, and cholangitis. Infections were identified until liver transplant, death or last follow-up with native liver. Infection-free survival was estimated by Kaplan-Meier analysis. Logistic regression was used to estimate odds of infection per clinical characteristics. Cluster analysis was performed to identify patterns of infection development.

Results

48 of 65 (73.8%) children had ≥1 infection during their disease course (mean length of follow up: 40.2 months). Cholangitis (n = 30) and VRI (n = 21) were most common. Nearly half (45%) of all infections developed within 3-months of Kasai hepatoportoenterostomy. Kasai performed ≥45 days of life was associated with 3.5-fold increased risk of any infection (95% CI 1.2–11.4). Risk of VRI was inversely related to platelet count at 1-month post-Kasai (OR 0.5, 0.19–0.99). Cluster analysis of infectious patterns identified three unique cohorts of patients based on their infection history: no/few infections (n = 18), mostly cholangitis (n = 20) or mixed infections (n = 27).

Conclusion

Variability of infection risk exists amongst children with BA. Age at Kasai and platelet count are risk factors for future infections, suggesting that patients with more severe disease are at greater risk. Cirrhosis associated immune deficiency may exist in chronic pediatric liver disease and should be the subject of future investigations in order to optimize outcomes.

Le texte complet de cet article est disponible en PDF.

Keywords : Viral respiratory infections, Bacteremia, Central line infections, Cholangitis, Kasai hepatoportoen-terostomy, Cirrhosis

Abbreviations : BA, CAID, CL, CLABSI, CLD, CRF, EMR, HPE, LT, PCR, PICC, RSV, SBP, UTI, VRI


Plan


© 2023  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 47 - N° 4

Article 102109- avril 2023 Retour au numéro
Article précédent Article précédent
  • MAdCAM-1 does not play a central role in the early pathophysiology of autoimmune hepatitis
  • F.F. van den Brand, H. Masrati, E.S. Jordanova, E. Bloemena, B.I. Lissenberg-Witte, Y.S. de Boer, H.J. Bontkes, R. Mebius, G. Bouma
| Article suivant Article suivant
  • An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis
  • Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.